Search  

Research Division

US Fertility’s Research Division conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to infertility patients.

NEW RESEARCH

The latest medical journal articles from USF-affiliated authors

Karine Matevossian, DO; Anne Rivelli, MA, MPH; Meike L. Uhler, MD. AJOG Clin Rep. Nov 2022.

A survey was emailed to medical trainees across a broad range of medical specialties to gather information about US residents and fellows’ fertility knowledge and their views on family planning. The responses from those who completed the survey suggest that women physicians and Ob/Gyn trainees do not have greater knowledge of basic female fertility than males or those in other specialties. Female trainees were less likely to be married or have children and more likely to report postponing childbearing.

Jonah Bardos, MD, Jacyln Kwal, MD, Wayne Caswell, MS, Samad Jahandideh, PhD, Melissa Stratton, BS, Michael Tucker, PhD, Alan Decherney, MD, Kate Devine, MD, Micah Hill, DO, Jeanne E. O’Brien, MD, MSc. Accepted, Fertil Steril. 2022.

This retrospective study gathered data from embryos of donor oocytes that underwent trophectoderm biopsy and PGT-A from four different laboratories to investigate variation in euploid blastocyst rate and live birth rate across different laboratories when controlling for blastocyst quality. Results from the study suggest that there are differences in euploid blastocyst rate and live birth rates for a young and healthy population between laboratories, suggesting that not all PGT-A laboratories are comparable.

Akers A, New EP, Plosker S, Silva CP, Sprague R, Imudia AN. Oocyte Retrieval in Asymptomatic Patients Positive for SARS-CoV-2. Case Rep Obstet Gynecol. 2022 Aug 12;2022:3107747. doi: 10.1155/2022/3107747. PMID: 35990707; PMCID: PMC9391171.

COVID-19 has created an additional barrier for women who wish to or are currently undergoing fertility treatment. Fertility centers should address asymptomatic, COVID-19 positive patients on a case-by-case basis in order to ensure safety to center staff and the patient, while also mitigating the dangers associated with cycle cancellation. This study is a discussion of two case studies where women underwent oocyte retrievals and were asymptomatic but tested positive for COVID-19. In both special cases, the risks of canceling the cycles were heavily considered by practice physicians and risk management, and extra precautions were taken to ensure no medical staff were also infected.

Siegel DR, Sheeder J, Kramer W, Roeca C. Are donor-conceived people willing to use donors themselves? Insights from individuals conceived via donor-assisted reproduction. Hum Reprod. 2022 Aug 25;37(9):2087-2094. doi: 10.1093/humrep/deac169. PMID: 35906918.

Utilizing a web-based survey that was distributed to users of the Sibling Donor Registry, this study found that 40.2% of people who were conceived using donor gametes would consider using donor gametes themselves and 24.6% were undecided. Those who were undecided or had already used donor gametes tended to be younger, and less likely to be married or identify as female than those who would not consider donor gametes.

Fanton M, Nutting V, Rothman A, Maeder-York P, Hariton E, Barash O, Weckstein L, Sakkas D, Copperman AB, Loewke K. An interpretable machine learning model for individualized gonadotrophin starting dose selection during ovarian stimulation. Reprod Biomed Online. 2022 Jul 28:S1472-6483(22)00498-9. doi: 10.1016/j.rbmo.2022.07.010. Epub ahead of print. PMID: 36096871.

A machine learning model was developed using de-identified, electronic medical record data from three IVF clinics to determine the best starting dose of FSH during ovarian stimulation per individual. This tool uses historical FSH dosing and clinical outcomes as a guideline for new patients starting ovarian stimulation and may help standardize care across fertility practices.

updated October 2022

“Given our culture, commitment to excellence, incredible volume of data, and unparalleled talent, there’s no limit to what we can accomplish as a network. Our Research Division celebrates the amazing contributions our research and education teams are making in collaboration across the US Fertility network, a network of innovation.”

Kate Devine, M.D.
Executive Medical Director and Chief Research Officer

Our Team

Research Division Leadership

KATE DEVINE, M.D.​

Executive Medical Director and Chief Research Officer

LUIS R. HOYOS, M.D.

Regional Research Director, IVF Florida

MEIKE L. UHLER, M.D.

Regional Research Director, Fertility Centers of Illinois

MICHAEL HOMER, M.D.

Regional Research Director, RSC Bay Area

Phillip Romanski, M.D.

Regional Research Director, SGF NY

Russell Hayden, M.D.

Regional Research Director, SGF PA

EMILY BARNARD, D.O.

Regional Research Director, SGF Baltimore

KATHRYN HUMM, M.D.

Regional Research Director, SGF DC

NICOLE DOYLE, M.D.

Regional Research Director, SGF Northern Virginia

BENJAMIN HARRIS, M.D., M.P.H

Regional Research Director, SGF Southern Virginia

JESSICA KANTER, M.D.

Regional Research Director, SGF Atlanta

ANTHONY IMUDIA, M.D.

Regional Research Director, SGF FL

JANET BRUNO-GASTON, M.D., MSCI, FACOG

Regional Research Director, SGF Houston

CASSANDRA ROECA, M.D.

Regional Research Director, SGF CO

CRISTIAN JESAM, M.D.

Regional Research Director, SGF Chile

Contact US

Let's work together.

Email us to become involved or to connect with our research team.